RORA Biologics
PrivateLast Round
Series A
Jun 1, 2024
Total Funding Raised
$16.5M
Company Overview
RORA Biologics operates in Healthcare & Life Sciences and is based in Brookhaven, Georgia. Its latest recorded funding round was a Series A round in June 2024.
RORA Biologics is a biotechnology company developing a T-cell platform that utilizes stem cell-like memory T cells to create more durable and safer CAR-T cell therapies for cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RORA Biologics Comparables
Compare RORA Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TriArm Therapeutics | 82% | |
| Addimmune | 77% | |
| American Gene Technologies | 76% |
For institutional investors. Book with your work email.
RORA Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2024 | ||||
| Seed | Jan 25, 2023 |
For institutional investors. Book with your work email.
RORA Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mesa Verde Venture Partners | Series A, Seed |
| Emory University | Series A |
| Gaingels | Series A, Seed |
| Georgia Research Alliance | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2024
$15M round led by Emory University and Georgia Research Alliance.
- Jan 25, 2023
$2M raised led by Mesa Verde Venture Partners and Ventac Partners.
For institutional investors. Book with your work email.
RORA Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RORA Biologics's valuation, stock price, and market status.
Is RORA Biologics a public or private company?
RORA Biologics is a private company.
What is the current stock price of RORA Biologics?
RORA Biologics is a private company, so its shares have no public market price. Caplight tracks RORA Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RORA Biologics worth (valuation)?
Valuation information for RORA Biologics is not publicly available.
Can I buy RORA Biologics stock?
RORA Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RORA Biologics's last funding round?
RORA Biologics's most recent funding round was Series A on June 1, 2024.
Who are the main investors in RORA Biologics?
Key investors in RORA Biologics include Mesa Verde Venture Partners, Emory University, Georgia Research Alliance.
Will RORA Biologics IPO soon?
No public IPO plans have been announced for RORA Biologics.
How can I track RORA Biologics secondary market activity?
Caplight tracks bids, offers, and trades in RORA Biologics's shares on secondary markets.